Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.19T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.47% | 20.86 | 16.03 | 0.26 | -1.98% | 5.00% | +56.62% | +10.77% | 0.90 | |||||
101 | ZLAB | Zai Lab Ltd | $17.07 | $1.92B | N/A | N/A | N/A | N/A | -5.68% | N/A | 77 | +95.08% | $33 | -36.85% | 0.89 |
102 | OCUL | Ocular Therapeutix Inc | $8.94 | $1.91B | -4.26% | N/A | N/A | N/A | -12.59% | N/A | 84 | +190.83% | $26 | -8.80% | 1.34 |
103 | VCEL | Vericel Corp | $37.46 | $1.91B | +35.66% | 87.95 | 78.74 | 0.15 | 2.49% | N/A | 71 | +47.97% | $55 | -8.30% | 1.16 |
104 | GLPG | Galapagos NV | $27.73 | $1.90B | N/A | 4.86 | 344.83 | 0.01 | -16.24% | N/A | 50 | +2.99% | $29 | -18.05% | 0.50 |
105 | STOK | Stoke Therapeutics Inc | $29.82 | $1.77B | +11.95% | N/A | 204.08 | N/A | -8.33% | N/A | 77 | +51.24% | $45 | -5.06% | 1.07 |
106 | TRVI | Trevi Therapeutics Inc | $14.21 | $1.72B | -27.09% | N/A | N/A | N/A | -2.64% | N/A | 79 | +68.19% | $24 | +44.06% | 0.64 |
107 | AGIO | Agios Pharmaceuticals Inc | $29.46 | $1.71B | N/A | N/A | 2.47 | N/A | -22.45% | N/A | 67 | +36.63% | $40 | -12.74% | 1.06 |
108 | INVA | Innoviva Inc | $22.74 | $1.70B | +16.74% | 3.31 | 11.51 | 0.33 | 10.72% | N/A | 62 | +56.11% | $36 | +12.22% | 0.19 |
109 | QURE | uniQure N.V. | $27.57 | $1.69B | +2.11% | N/A | 27.93 | N/A | -10.22% | N/A | 69 | +41.31% | $39 | -4.60% | 1.33 |
110 | RAPP | Rapport Therapeutics Inc | $38.40 | $1.68B | N/A | N/A | N/A | N/A | -4.79% | N/A | 77 | +48.70% | $57 | 0.00% | 1.33 |
111 | ZYME | Zymeworks BC Inc | $22.88 | $1.67B | N/A | N/A | 22.94 | N/A | -4.61% | N/A | 78 | +71.46% | $39 | -9.62% | 0.86 |
112 | BHVN | Biohaven Ltd | $11.29 | $1.67B | N/A | N/A | N/A | N/A | -35.68% | N/A | 73 | +92.29% | $22 | 0.00% | 1.52 |
113 | IOVA | Iovance Biotherapeutics Inc | $4.08 | $1.66B | -12.60% | N/A | N/A | N/A | -18.42% | N/A | 75 | +115.69% | $8.80 | -29.76% | 1.68 |
114 | VRDN | Viridian Therapeutics Inc | $16.35 | $1.62B | -32.36% | N/A | 1.01 | N/A | -18.80% | N/A | 77 | +107.58% | $34 | -0.40% | 1.11 |
115 | RXRX | Recursion Pharmaceuticals Inc - Class A | $3.15 | $1.61B | -10.03% | N/A | N/A | N/A | -20.20% | N/A | 65 | +110.79% | $6.64 | -37.55% | 2.62 |
116 | NBTX | Nanobiotix | $35.54 | $1.60B | -5.64% | N/A | 95.24 | N/A | -3.86% | N/A | 67 | +20.29% | $43 | +17.89% | 1.10 |
117 | SRPT | Sarepta Therapeutics Inc | $15.31 | $1.60B | N/A | 4.19 | 4.97 | 159.25 | 7.20% | N/A | 51 | +43.70% | $22 | -29.21% | 1.41 |
118 | NUVB | Nuvation Bio Inc - Class A | $4.92 | $1.59B | N/A | N/A | N/A | N/A | -7.92% | N/A | 77 | +150.61% | $12 | -15.48% | 1.52 |
119 | NRIX | Nurix Therapeutics Inc | $16.95 | $1.58B | N/A | N/A | N/A | N/A | -17.18% | N/A | 82 | +82.89% | $31 | -10.52% | 1.37 |
120 | AAPG | Ascentage Pharma Group International | $17.60 | $1.58B | N/A | N/A | N/A | N/A | -16.69% | N/A | 81 | +170.23% | $48 | 0.00% | 0.70 |
121 | RAPT | RAPT Therapeutics Inc | $58.02 | $1.56B | N/A | N/A | N/A | N/A | -5.54% | N/A | N/A | N/A | N/A | -17.14% | N/A |
122 | SNDX | Syndax Pharmaceuticals Inc | $18.25 | $1.56B | +12.13% | N/A | N/A | N/A | -17.88% | N/A | 78 | +113.70% | $39 | -0.70% | 1.06 |
123 | TSHA | Taysha Gene Therapies Inc | $5.71 | $1.55B | N/A | N/A | N/A | N/A | -7.27% | N/A | 80 | +114.19% | $12 | -25.99% | 1.40 |
124 | ABCL | AbCellera Biologics Inc | $5.24 | $1.55B | N/A | N/A | 27.55 | N/A | -12.23% | N/A | 75 | +99.05% | $10 | -26.57% | 1.68 |
125 | FTRE | Fortrea Holdings Inc | $16.48 | $1.55B | N/A | N/A | 12.89 | 0.34 | 14.28% | N/A | 52 | -1.64% | $16 | 0.00% | 1.90 |
126 | SION | Sionna Therapeutics Inc | $35.92 | $1.53B | N/A | N/A | N/A | N/A | -4.70% | N/A | 68 | +43.65% | $52 | 0.00% | 0.96 |
127 | ANAB | AnaptysBio Inc | $56.07 | $1.51B | -4.15% | N/A | N/A | N/A | 0.29% | N/A | 81 | +55.32% | $87 | +27.57% | 0.81 |
128 | TYRA | Tyra Biosciences Inc | $26.99 | $1.51B | N/A | N/A | N/A | N/A | -6.78% | N/A | 76 | +91.18% | $52 | 0.00% | 1.06 |
129 | MBX | MBX Biosciences Inc | $35.51 | $1.47B | N/A | N/A | N/A | N/A | -5.41% | N/A | 75 | +94.56% | $69 | 0.00% | 1.49 |
130 | NTLA | Intellia Therapeutics Inc | $12.11 | $1.47B | +8.10% | N/A | N/A | N/A | -24.75% | N/A | 60 | +119.90% | $27 | -32.74% | 1.73 |
131 | PVLA | Palvella Therapeutics Inc | $108.81 | $1.46B | N/A | N/A | N/A | N/A | -1.99% | N/A | 75 | +111.01% | $230 | 0.00% | 1.03 |
132 | CAPR | Capricor Therapeutics Inc | $25.80 | $1.46B | +22.65% | N/A | 78.74 | N/A | -6.83% | N/A | 80 | +109.73% | $54 | +41.12% | 1.49 |
133 | IMCR | Immunocore Holdings plc | $28.96 | $1.42B | N/A | N/A | 192.31 | N/A | -2.17% | N/A | 70 | +119.23% | $63 | -6.11% | 0.74 |
134 | NVAX | Novavax Inc | $8.88 | $1.41B | -42.97% | N/A | 2.59 | 1.32 | -6.51% | N/A | 50 | +58.90% | $14 | -46.77% | 1.50 |
135 | NKTR | Nektar Therapeutics | $59.38 | $1.40B | -24.01% | N/A | 34.01 | 0.31 | -14.52% | N/A | 75 | +158.08% | $153 | -25.87% | 1.84 |
136 | GLUE | Monte Rosa Therapeutics Inc | $18.24 | $1.39B | N/A | N/A | 10.02 | N/A | -1.41% | N/A | 81 | +77.30% | $32 | 0.00% | 1.37 |
137 | ARDX | Ardelyx Inc | $5.69 | $1.39B | -26.76% | N/A | 40.65 | N/A | -2.71% | N/A | 77 | +186.99% | $16 | -5.15% | 0.79 |
138 | KALV | KalVista Pharmaceuticals Inc | $27 | $1.38B | +11.29% | N/A | 25.45 | N/A | -4.74% | N/A | 53 | 0.00% | $27 | -0.96% | 0.85 |
139 | ATAI | ATAI Life Sciences N.V. | $3.92 | $1.38B | N/A | N/A | N/A | N/A | -7.50% | N/A | 78 | +257.14% | $14 | 0.00% | 1.49 |
140 | AVBP | ArriVent BioPharma Inc | $30.54 | $1.38B | N/A | N/A | N/A | N/A | -9.73% | N/A | 75 | +37.85% | $42 | 0.00% | 0.96 |
141 | PGEN | Precigen Inc | $4.45 | $1.37B | -3.77% | N/A | 222.22 | N/A | -8.52% | N/A | 75 | +179.78% | $12 | -8.79% | 1.69 |
142 | SEPN | Septerna Inc | $35.95 | $1.37B | N/A | N/A | 107.53 | N/A | 7.81% | N/A | 77 | +27.34% | $46 | 0.00% | 1.34 |
143 | URGN | UroGen Pharma Ltd | $29.72 | $1.36B | -11.74% | N/A | N/A | N/A | -12.17% | N/A | 75 | +24.09% | $37 | +11.35% | 1.19 |
144 | VIR | Vir Biotechnology Inc | $8.61 | $1.33B | -0.01% | N/A | 4.27 | N/A | -33.80% | N/A | 82 | +150.41% | $22 | -28.33% | 1.56 |
145 | BCAX | Bicara Therapeutics Inc | $21.69 | $1.32B | N/A | N/A | N/A | N/A | -8.80% | N/A | 75 | +45.04% | $31 | 0.00% | 1.43 |
146 | INBX | Inhibrx Biosciences Inc | $92.20 | $1.31B | N/A | N/A | N/A | N/A | -10.10% | N/A | 66 | +200.98% | $278 | 0.00% | 1.41 |
147 | SLS | SELLAS Life Sciences Group Inc | $7.83 | $1.30B | -32.56% | N/A | N/A | N/A | -2.17% | N/A | 87 | +27.71% | $10 | -8.77% | 0.94 |
148 | GHRS | GH Research PLC | $21.12 | $1.26B | +89.13% | N/A | N/A | N/A | -3.68% | N/A | 83 | +87.03% | $40 | 0.00% | 1.02 |
149 | MPLT | MapLight Therapeutics Inc | $27.75 | $1.26B | N/A | N/A | N/A | N/A | -17.99% | N/A | 79 | +39.46% | $39 | 0.00% | 1.57 |
150 | MLTX | MoonLake Immunotherapeutics - Class A | $18.69 | $1.25B | N/A | N/A | N/A | N/A | -17.98% | N/A | 66 | +47.78% | $28 | +13.16% | 0.96 |